MyFinsight
Home
Blog
About
Maturities of marketable
securities
$89,300K
(-45.84%↓ Y/Y)
something is missing
$4,644K
Proceeds from issuance of
common stock under...
$652K
(-12.83%↓ Y/Y)
Net cash provided by
(used in) investing...
$40,841K
(476.45%↑ Y/Y)
Net cash provided by
(used in) financing...
$1,107K
(148.21%↑ Y/Y)
Canceled cashflow
$48,459K
Canceled cashflow
$4,189K
Net change in cash
and cash...
-$3,948K
(95.46%↑ Y/Y)
Canceled cashflow
$41,948K
Stock-based compensation
expense, including...
$12,903K
(42.26%↑ Y/Y)
Other current
liabilities
$8,032K
(453.55%↑ Y/Y)
Non-cash lease expense
$300K
(-47.83%↓ Y/Y)
Depreciation and
amortization expense
$102K
(-60.77%↓ Y/Y)
Prepaid expenses and
other current assets
-$75K
(-105.74%↓ Y/Y)
Purchases of marketable
securities
$48,238K
(-72.55%↓ Y/Y)
Purchase of equipment
$221K
Proceeds from exercise of
stock options
-$4,189K
(-991.28%↓ Y/Y)
Net cash used in
operating activities
-$45,896K
(37.86%↑ Y/Y)
Canceled cashflow
$21,412K
Net loss
-$63,200K
(14.79%↑ Y/Y)
Accounts payable
-$1,905K
(46.58%↑ Y/Y)
Non-cash interest income
on marketable...
$1,221K
(-67.99%↓ Y/Y)
Other assets and
long-term deposits
$668K
(-61.57%↓ Y/Y)
Operating lease
liabilities
-$314K
(49.35%↑ Y/Y)
Back
Back
Cash Flow
Olema Pharmaceuticals, Inc. (OLMA)
Olema Pharmaceuticals, Inc. (OLMA)
source: myfinsight.com